Wednesday, April 7, 2010 as of 11:14 AM ET
Amylin Pharmaceuticals is a biopharmaceutical company based in San Diego, CA, that was founded in 1987. The company is engaged in the discovery, development and commercialization of drug candidates for the treatment of diabetes, obesity and other diseases.
Read More at Wikipedia ›The Health Care sector (XLV) held steady on a trading day that saw S&P 500 drop 0.
3%.The ETF, as a proxy for the sector, tracked closer to the overall market today than over the past month. As trading began today, XLV was down 2.9% over the last thirty trading days, and the S&P 500 climbed -5.8%.Insulet Corporation (NASDAQ:PODD) declined 3.5% to close at $18, moving below its 50-day moving average of $18.13 and 200-day moving average of $18.45.MAP Pharmaceuticals (NASDAQ:MAPP) rose 6.7% to close at $12.15, approaching its 50-day moving average of $12.57. It has also moved closer to its 200-day moving average of $14.11. ABIOMED (NASDAQ:ABMD) fell 5.1% to close at $20.80, moving down to 1.8% above its 200-day moving average of $20.44.Elan Corporation plc (NYSE:ELN) was a significant gainer in the sector, rising 8.4%. The stock closed at $14.30 with 8.5 million shares moving. The stock traded in a range of $13.22 to $14.49. Share price is up 45 cents (3.2%) from $13.85 on April 26, 2012. ...A consumer advocacy group is asking the U.S. Food and Drug Administration to remove Novo Nordisk's (NVO, NOVO-B.KO) diabetes drug Victoza from the market because of ...
FBN’s Robert Gray on Carl Icahn suing Amylin for more time to nominate directors to help pressure the company to accept a takeover bid.
Carl Icahn sued Amylin Pharmaceuticals Inc to block enforcement of a bylaw that prevents the billionaire investor from launching a proxy fight that could lead to a s...
FBN's Lauren Simonetti breaks down late-morning market news.
FBN’s Robert Gray on reports Bristol-Myers is still considering acquiring Amylin Pharmaceuticals .
Billionaire investor Carl Icahn blasted the Amylin (NASDAQ:AMLN) board in an open letter sent Wednesday for rejecting a reported offer by Bristol-Myers Squibb (NYSE:...
These stocks set one-year highs:The share price of UnitedHealth Group (NYSE: UNH ) rose today, reaching and then surpassing its previous 52-week high of $56.34. The ...
Shares of Amylin Pharmaceuticals Inc (NASDAQ:AMLN) rose as much as 51 percent on Wednesday after Bloomberg News reported the company rejected a $3.5 billion unsolici...
DOW JONES NEWSWIRESAmylin Pharmaceuticals Inc. (AMLN) and Eli Lilly & Co. (LLY) said the European Commission approved its type 2 diabetes treatment Byetta as an add-...
("FDA Approves Eli Lilly Diabetes Combo Drug Jentadueto" at 7:33 p.m. ET on Jan. 30 and the update at 8:05 p.m. ET on Jan. 30 misstated how often the drug is taken d...
Eli Lilly & Co. (LLY) reported a 27% decline in fourth-quarter profit, as sales of antipsychotic Zyprexa took a big hit from new generic competition.The Indianapolis...
U.S. stocks edged lower Monday as investors fixed their attention on the standoff between Greece and its private creditors and a surge in Portugal's borrowing costs....
Here are stocks that are up on high volume:Sara Lee (NYSE:SLE) experienced a price hike on above-average volume today, trading at a volume of 14 million, or 1.6 time...
During trading today, the S&P 500 dropped 0.6%, and the Health Care sector (XLV) showed little change.The ETF, as a proxy for the sector, tracked closer to the overa...
Today, these stocks are up on high volume:Today, TJX Cos (NYSE:TJX) is up on high volume, trading at a volume of 9.4 million, or 1.9 times its average daily volume. ...
These are the nine most popular stocks that rose to 52-week highs:While trading on above-average volume, Colgate-Palmolive (NYSE:CL) climbed today, reaching and then...
Shares of Amylin Pharmaceuticals climbed 6% in early trading Tuesday after analysts at Leerink Swann said they see Sanofi and Merck emerging as the strongest bidders...
DOW JONES NEWSWIRESActivist Investor Carl Icahn said he has dropped a lawsuit against Amylin Pharmaceuticals Inc. (AMLN) that sought to extend the drug maker's board...
Financier Carl Icahn said he has voluntarily dismissed a lawsuit filed against Amylin Pharmaceuticals Inc after talking with the biotech company's Chief Executive Of...
Quotes delayed at least 15 minutes. Real-time quotes provided by BATS Exchange. Market Data provided by Interactive Data (Terms & Conditions). Powered and Implemented by Interactive Data Managed Solutions. Company fundamental data provided by Morningstar. Earnings estimates data provided by Zacks. Mutual fund data provided by Lipper. Economic data provided by Econoday. Dow Jones & Company Terms & Conditions.
This material may not be published, broadcast, rewritten, or redistributed. ©2012 FOX News Network, LLC. All rights reserved.
